Kerydin

Chemical Nametavaborole
Dosage FormSolution (topical; 5%)
Drug ClassAntifungals
SystemSkin
CompanyPfizer
Approval Year2014

Indication

  • For the topical treatment of onychomycosis of the toenails due to Trichophyton rubrum or Trichophyton mentagrophytes.
Last updated on 7/14/2022

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Kerydin (tavaborole) Prescribing Information.2018Pfizer Inc., New York, NY
Document TitleYearSource
Topical and device-based treatments for fungal infections of the toenails (review). 2020Cochrane Database of Systematic Reviews